[Prolonged partial remission of a hepatocellular carcinoma treated with adriamycin and recombinant human alpha-2 interferon]. / Rémission partielle prolongée d'un carcinome hépatocellulaire traité par adriamycine et interféron alpha-2 human recombinant.
Ann Gastroenterol Hepatol (Paris)
; 27(5): 211-4, 1991 Oct.
Article
em Fr
| MEDLINE
| ID: mdl-1660687
ABSTRACT
Adriamycin is one of the chemotherapeutic agent often administered in the treatment of unresectable hepatocellular carcinoma. On monotherapy, the reported rate response is between 0 to 15 p. cent, without improvement on survival. Its combination with other cytotoxic molecules, such as interferon, has been suggested to improve the percentage of response rates. We present the case of a 73 years old man, who underwent a prolonged partial response of a hepatocellular carcinoma with adriamycin and recombinant human interferon alpha-2.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Indução de Remissão
/
Doxorrubicina
/
Interferon Tipo I
/
Carcinoma Hepatocelular
/
Alcoolismo
/
Neoplasias Hepáticas
Tipo de estudo:
Etiology_studies
Limite:
Aged
/
Humans
/
Male
Idioma:
Fr
Revista:
Ann Gastroenterol Hepatol (Paris)
Ano de publicação:
1991
Tipo de documento:
Article